Erratum: Tertiary lymphoid structures in hepatocellular carcinoma: influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy

作者：Jia‐Yong Su, Jian-Rong Li, Li-Xin Pan, Yi-Li Ma, Wei Tian, Yu-mian Jiang, Ping-Ping Guo, Le Li, Zhu-Jian Deng, Zhen-Zhen Li, Cheng‐Piao Luo, Rong‐Rui Huo, Liang Ma, Jian‐Hong Zhong · 发表于：Hepatology · 年份：2026 · DOI：10.1097/hep.0000000000001517 · 研究领域：Cancer Immunotherapy and Biomarkers、Hepatocellular Carcinoma Treatment and Prognosis、Immunotherapy and Immune Responses

In the original article by Su et al,1 an error inadvertently occurred in Table 1. Under the “Sex” item, the positions of male and female entries were mistakenly swapped; however, the data statistics themselves are correct. Table 1 has been updated accordingly in this issue to reflect the correction. The corrected table can also be seen below. TABLE 1 - Comparison of baseline clinicodemographic characteristics between patients in the GXMUCH-1 dataset who received adjuvant PD-1 inhibitor therapy and whose tumors contained TLS or not, before and after propensity score matching Before matching After matching Characteristic No TLS (n=86) TLS (n=109) P No TLS (n=63) TLS (n=63) P Sex 0.821 1.000 Female 12 (14.0) 14 (12.8) 7 (11.1) 7 (11.1) Male 74 (86.0) 95 (87.2) 56 (88.9) 56 (88.9) Age, yr 49.7±10.5 51.7±10.6 0.177 49.4±10.8 50.1±10.6 0.747 Total bilirubin, µmol/L 0.976 0.851 <17.1 59 (68.6) 75 (68.8) 42 (66.7) 41 (65.1) ≥17.1 27 (31.4) 34 (31.2) 21 (33.3) 22 (34.9) Albumin, g/L 0.597 0.770 ≥35 77 (89.5) 100 (91.7) 57 (90.5) 56 (88.9) <35 9 (10.5) 9 (8.3) 6 (9.5) 7 (11.1) Alanine aminotransferase, U/L 0.785 0.543 ≤ 40 60 (69.8) 78 (71.6) 48 (76.2) 45 (71.4) > 40 26 (30.2) 31 (28.4) 15 (23.8) 18 (28.6) HBV DNA, IU/mL 0.554 0.688 <20 25 (29.1) 36 (33.0) 18 (28.6) 16 (25.4) ≥20 61 (70.9) 73 (67.0) 45 (71.4) 47 (74.6) Antivirus therapy 75 (87.2) 94 (86.2) 0.843 57 (90.5) 57 (90.5) 1.000 HBsAg 0.932 0.571 Negative 13 (15.1) 16 (14.7) 8 (12.7) 6 (9.5) Positive 73 (84.9) 93 (85.3) 55 (87...